Grassley says FDA was aware of Avandia danger

05/25/2007 | Washington Post (tiered subscription model), The

Sen. Charles Grassley, R-Iowa, said the FDA's own preliminary evaluation indicated significant heart risk from the GlaxoSmithKline diabetes drug Avandia. Grassley also noted FDA safety watchdogs urged a black-box warning for the drug several months ago, and he criticized the FDA for wanting to wait up to two years for data from a new clinical trial.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC